Mai H - Search Results

1

Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise.

Dai WF, Craig E, Fraser B, Chambers A, Mai H, Brown MB, Earle CC, Evans WK, Geirnaert M, Taylor M, Trudeau M, Sperber D, Beca JM, Denburg A, Mercer RE, Parmar A, Tadrous M, Takhar P, Chan KKW, On Behalf Of The CanREValue Collaboration. Dai WF, et al. Among authors: mai h. Curr Oncol. 2021 Nov 12;28(6):4645-4654. doi: 10.3390/curroncol28060392. Curr Oncol. 2021. PMID: 34898572 Free PMC article.

2

Reimbursement recommendations for cancer drugs supported by phase II evidence in Canada.

Li YYR, Mai H, Trudeau ME, Mittmann N, Chiasson K, Chan KKW, Cheung MC. Li YYR, et al. Among authors: mai h. Curr Oncol. 2020 Oct;27(5):e495-e500. doi: 10.3747/co.27.6489. Epub 2020 Oct 1. Curr Oncol. 2020. PMID: 33173389 Free PMC article.

3

[No title available]

[No authors listed] [No authors listed] PMID: 33704137

4

What does meaningful look like? A qualitative study of patient engagement at the Pan-Canadian Oncology Drug Review: perspectives of reviewers and payers.

Rozmovits L, Mai H, Chambers A, Chan K. Rozmovits L, et al. Among authors: mai h. J Health Serv Res Policy. 2018 Apr;23(2):72-79. doi: 10.1177/1355819617750686. Epub 2018 Apr 6. J Health Serv Res Policy. 2018. PMID: 29624087

5

The impact of pricing strategy on the costs of oral anti-cancer drugs.

Truong J, Chan KKW, Mai H, Chambers A, Sabharwal M, Trudeau ME, Cheung MC. Truong J, et al. Among authors: mai h. Cancer Med. 2019 Jul;8(8):3770-3781. doi: 10.1002/cam4.2269. Epub 2019 May 27. Cancer Med. 2019. PMID: 31132223 Free PMC article.

6

Are We Making a Difference? A Qualitative Study of Patient Engagement at the pan-Canadian Oncology Drug Review: Perspectives of Patient Groups.

Mercer RE, Chambers A, Mai H, McDonald V, McMahon C, Chan KKW. Mercer RE, et al. Among authors: mai h. Value Health. 2020 Sep;23(9):1157-1162. doi: 10.1016/j.jval.2020.06.003. Epub 2020 Aug 7. Value Health. 2020. PMID: 32940233 Free article.

7

Clinician participation in CADTH's pan-Canadian Oncology Drug Review: contribution and impact on cancer drug funding recommendations.

Trudeau M, Hoskins P, Reiman T, Chambers A, Mai H, Wheatley-Price P. Trudeau M, et al. Among authors: mai h. Curr Oncol. 2017 Apr;24(2):71-74. doi: 10.3747/co.24.3644. Epub 2017 Apr 27. Curr Oncol. 2017. PMID: 28490919 Free PMC article. No abstract available.

8

The impact of cancer drug wastage on economic evaluations.

Truong J, Cheung MC, Mai H, Letargo J, Chambers A, Sabharwal M, Trudeau ME, Chan KKW. Truong J, et al. Among authors: mai h. Cancer. 2017 Sep 15;123(18):3583-3590. doi: 10.1002/cncr.30807. Epub 2017 Jun 22. Cancer. 2017. PMID: 28640362 Free article.

9

Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding.

Srikanthan A, Mai H, Penner N, Amir E, Laupacis A, Sabharwal M, Chan KKW. Srikanthan A, et al. Among authors: mai h. Curr Oncol. 2017 Oct;24(5):295-301. doi: 10.3747/co.24.3648. Epub 2017 Oct 25. Curr Oncol. 2017. PMID: 29089796 Free PMC article.

10

Evaluation of the impact of patient involvement in health technology assessments: A scoping review.

Mason RJ, Searle KM, Bombard Y, Rahmadian A, Chambers A, Mai H, Morrison M, Chan KKW, Jerzak KJ. Mason RJ, et al. Among authors: mai h. Int J Technol Assess Health Care. 2020 Jun;36(3):217-223. doi: 10.1017/S0266462320000239. Epub 2020 May 8. Int J Technol Assess Health Care. 2020. PMID: 32383420 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,098 results

Search Page

Filters